Coronavirus: Operation Warp Speed
Using the resources of the federal government and the U.S. private sector, Operation Warp Speed (OWS) will accelerate the testing, supply, development, and distribution of safe and effective vaccines, therapeutics, and diagnostics to counter COVID-19 by January 2021.
OWS is an unprecedented leap toward a historic breakthrough that will save countless lives.
OWS is leveraging the best, most talented experts from across the federal government and private industry to develop safe and effective vaccines and therapeutics quickly without compromising safety.
Developing a Vaccine
(Visual illustrating OWS vaccine development VS traditional)
Vaccine Delivery Milestones
Vaccine Distribution Process
On May 15, 2020, the White House announced Operation Warp Speed to accelerate development, production, and distribution of COVID-19 vaccines, therapeutics, and diagnostics to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021.
Contributing stakeholders: Department of Defense, Department of Health and Human Services, including the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, the National Institutes of Health and the Biomedical Advanced Research and Development Authority.
OWS has five focus areas: Development and testing of vaccines; development and testing of therapeutics; development and testing of diagnostics; supply production and distribution of vaccines, diagnostics and therapeutics; security and assurance of vaccine, diagnostic and therapeutic development, testing, supply, production and distribution.
Content retrieved from: https://www.defense.gov/Explore/Spotlight/Coronavirus/Operation-Warp-Speed/.